Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10999 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Vakalopoulou S., Slavakis A., Simoulidou E., Rakitzi P., Garipidou V., et al. (2009).  Hypoglycemia in a patient with advanced Sezary syndrome.. Leuk Lymphoma. 50(2), 284-6.
Anagnostis, P., Bosdou J. K., Vaitsi K., Goulis D. G., & Lambrinoudaki I. (2020).  Estrogen and bones after menopause: a reappraisal of data and future perspectives.. Hormones (Athens).
Anagnostis, P., Adamidou F., Slavakis A., Polyzos S. A., Selalmatzidou D., Panagiotou A., et al. (2014).  Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study.. Open Cardiovasc Med J. 8, 55-60.
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Panagiotou A., & Kita M. (2011).  Non-functioning pituitary adenomas: a single center experience.. Exp Clin Endocrinol Diabetes. 119(5), 314-9.
Anagnostis, P., Pliakos I., Panidis S., Chorti A., Stelmach V., Michalopoulos A., et al. (2019).  Should total thyroidectomies be performed by high-volume endocrine surgeons? A cost-effectiveness analysis.. Endocrine.
Anagnostis, P., Paschou S. A., Gonzalez-Rodriguez E., Potoupnis M., Tsiridis E., Lamy O., et al. (2019).  Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases.. J Clin Rheumatol.
Anagnostis, P., Karras S., Paschou S. A., & Goulis D. G. (2015).  Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk.. Blood Coagul Fibrinolysis. 26(6), 599-603.
Anagnostis, P., Gkekas N. K., Achilla C., Pananastasiou G., Taouxidou P., Mitsiou M., et al. (2020).  Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis.. Calcif Tissue Int. 107(5), 453-463.
Anagnostis, P., Efstathiadou Z. A., Polyzos S. A., Adamidou F., Slavakis A., Sapranidis M., et al. (2011).  Acromegaly: presentation, morbidity and treatment outcomes at a single centre.. Int J Clin Pract. 65(8), 896-902.
Anagnostis, P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., & Goulis D. G. (2019).  Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?. Curr Vasc Pharmacol. 17(6), 564-572.
Anagnostis, P., Paparodis R. D., Bosdou J. K., Bothou C., Macut D., Goulis D. G., et al. (2021).  Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.. Endocrine. 74(2), 245-253.
Anagnostis, P., Vakalopoulou S., Vyzantiadis T-A., Charizopoulou M., Karras S., Goulis D. G., et al. (2014).  The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B.. Haemophilia. 20(2), 268-75.
Anagnostis, P., Goulis D. G., & Mikhailidis D. P. (2020).  Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives.. Curr Pharm Des. 26(43), 5547-5550.
Anagnostis, P., Dimopoulou C., Karras S., Lambrinoudaki I., & Goulis D. G. (2015).  Sarcopenia in post-menopausal women: Is there any role for vitamin D?. Maturitas. 82(1), 56-64.
Anagnostis, P., Vaitsi K., Veneti S., Georgiou T., Paschou S. A., Lambrinoudaki I., et al. (2019).  Management of dyslipidaemias in the elderly population-A narrative review.. Maturitas. 124, 93-99.
Anagnostis, P., Vakalopoulou S., Charizopoulou M., Karras S., & Garipidou V. (2013).  Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity.. Haemophilia. 19(5), e308-10.
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Karathanassi E., & Kita M. (2012).  Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.. Pituitary. 15(1), 25-9.
Anagnostis, P., Karras S. N., & Goulis D. G. (2015).  Bone disease in patients with haemophilia A and B--where are we now?. Haemophilia. 21(1), 1-3.
Anagnostis, P., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".. J Clin Endocrinol Metab. 105(1), 
Anagnostis, P., Vyzantiadis T-A., Charizopoulou M., Adamidou F., Karras S., Goulis D. G., et al. (2013).  The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.. Thromb Haemost. 110(2), 257-63.
Anagnostis, P., Lambrinoudaki I., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2019).  Drug holidays in osteoporosis treatment: mind the gaps!. Osteoporos Int. 30(12), 2523-2524.
Anagnostis, P., Katsiki N., Athyros V. G., & Karagiannis A. (2014).  Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay.. Angiology.
Anagnostis, P., Vakalopoulou S., Christoulas D., Paschou S. A., Papatheodorou A., Garipidou V., et al. (2018).  The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.. Haemophilia. 24(2), 316-322.
Anagnostis, P., Florentin M., Livadas S., Lambrinoudaki I., & Goulis D. G. (2022).  Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.. Int J Mol Sci. 23(3), 
Anagnostis, P., Selalmatzidou D., Sapranidis M., Panagiotou A., Polyzos S. A., Slavakis A., et al. (2012).  Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study.. Indian J Endocrinol Metab. 16(1), 146-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.